Splenic marginal zone lymphoma epidemiology and demographics: Difference between revisions

	Splenic marginal zone lymphoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Splenic marginal zone lymphoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
Biopsy
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Splenic marginal zone lymphoma epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Splenic marginal zone lymphoma epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Splenic marginal zone lymphoma epidemiology and demographics
CDC on Splenic marginal zone lymphoma epidemiology and demographics
Splenic marginal zone lymphoma epidemiology and demographics in the news
Blogs on Splenic marginal zone lymphoma epidemiology and demographics
Directions to Hospitals Treating Splenic marginal zone lymphoma
Risk calculators and risk factors for Splenic marginal zone lymphoma epidemiology and demographics

VisualWikitext

Revision as of 18:54, 14 January 2016

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2], Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [3]

Overview

The incidence of splenic marginal zone lymphoma increases with age; the median age at diagnosis is 50 years. Splenic marginal zone lymphoma affects men and women equally.^[1]

Epidemiology

Age

The incidence of splenic marginal zone lymphoma increases with age; the median age at diagnosis is 50 years.^[1]

Gender

Splenic marginal zone lymphoma affects men and women equally.^[1]

References

↑ ^1.0 ^1.1 ^1.2 [1] Berger F, Felman P, Thieblemont C, Pradier T, Baseggio L, Bryon PA, Salles G, Callet-Bauchu E, Coiffier B. "Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients." Blood. 2000 Mar 15;95(6):1950-6. PMID: 10706860

Template:WH Template:WS

[ber1-1] 1.0 ^1.1 ^1.2 [1] Berger F, Felman P, Thieblemont C, Pradier T, Baseggio L, Bryon PA, Salles G, Callet-Bauchu E, Coiffier B. "Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients." Blood. 2000 Mar 15;95(6):1950-6. PMID: 10706860

[1]

@@ Line 1: / Line 1: @@
 __NOTOC__
 {{Splenic marginal zone lymphoma}}
-{{CMG}}
+{{CMG}}, {{AE}} {{AS}}
 ==Overview==
+The incidence of splenic marginal zone lymphoma increases with age; the median age at diagnosis is 50 years.  Splenic marginal zone lymphoma affects men and women equally.<ref name="ber1">
+[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=10706860&query_hl=7&itool=pubmed_ExternalLink]
+Berger F, Felman P, Thieblemont C, Pradier T, Baseggio L, Bryon PA, Salles G, Callet-Bauchu E, Coiffier B. "Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients." '''Blood'''. 2000 Mar 15;95(6):1950-6. PMID: 10706860</ref>
 ==Epidemiology==
-Less than 1% of all lymphomas are splenic marginal zone lymphomas<ref name="arm1"> [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=9704731&query_hl=5&itool=pubmed_ExternalLink]
+===Age===
-Armitage JO, Weisenburger DD. "New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project." '''J Clin Oncol.''' 1998 Aug;16(8):2780-95. PMID: 9704731</ref> and it is postulated that SMZL may represent a large fraction of unclasssifiable CD5- chronic lymphocytic leukemias.<ref name="who1">[http://www.iarc.fr/WHO-BlueBooks/BBwebsite/bb3.html] Jaffe E.S., Harris N.L., Stein H., Vardiman J.W. (eds): '''World Health Organization Classification of Tumors. Pathology and Genetics of Tumours of Haemopoietic and Lymphoid Tissues.''' IARC Press: Lyon 2001 </ref>The typical patient is over the age of 50, and gender preference has been described.<ref name="ber1">
+The incidence of splenic marginal zone lymphoma increases with age; the median age at diagnosis is 50 years.<ref name="ber1">
+[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=10706860&query_hl=7&itool=pubmed_ExternalLink]
+Berger F, Felman P, Thieblemont C, Pradier T, Baseggio L, Bryon PA, Salles G, Callet-Bauchu E, Coiffier B. "Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients." '''Blood'''. 2000 Mar 15;95(6):1950-6. PMID: 10706860</ref>
+===Gender===
+Splenic marginal zone lymphoma affects men and women equally.<ref name="ber1">
 [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=10706860&query_hl=7&itool=pubmed_ExternalLink]
 Berger F, Felman P, Thieblemont C, Pradier T, Baseggio L, Bryon PA, Salles G, Callet-Bauchu E, Coiffier B. "Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients." '''Blood'''. 2000 Mar 15;95(6):1950-6. PMID: 10706860</ref>
 ==References==
 {{reflist|2}}